JSM 2011 Online Program

The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.


414 *	Tue, 8/2/2011, 2:00 PM - 3:50 PM	CC-C224
Bayesian Analysis in Clinical Trials — Contributed Papers
Biopharmaceutical Section , Section on Bayesian Statistical Science
Chair(s): MaryAnn Morgan-Cox, Eli Lilly and Company
2:05 PM	Analysis of Drug Effect on Counts of Lymphocyte Subsets — Jiacheng Yuan, Astellas Pharma Global Development, Inc.
2:20 PM	An Approach to Bayesian Sample Sizing — Robb Muirhead, Statistical Consulting ; Adina Soaita, Pfizer Inc.
2:35 PM	Using Bayesian Method to Predict Responders Based on Clinical Scores in the Initial Weeks of Treatment in a Phase II Multiple Sclerosis Trial — Dazhe Wang, sanofi-aventis ; Lynn Wei, sanofi-aventis
2:50 PM	A Dose-Finding Design for Combination Therapy with Bayesian Bivariate Ordinal Probit Model — Rui Qin, Mayo Clinic ; Jianchang Lin, Florida State University ; Sumithra J. Mandrekar, Mayo Clinic ; Daniel J. Sargent, Mayo Clinic
3:05 PM	A Risk Assessment Framework for Decisionmaking in Drug Product Development — Amit Phansalkar, Straight Line Performance Solutions
3:20 PM	A Transparent and Efficient Approach in Proof-of-Concept Study Design and Subsequent Decisionmaking — Gang Jia, Merck & Co., Inc. ; Paul Delucca, Merck & Co., Inc. ; Bruce Binkowitz, Merck & Co., Inc. ; Daniel Bloomfield, Merck & Co., Inc.
3:45 PM	Floor Discussion

2011 JSM Online Program Home

For information, contact jsm@amstat.org or phone (888) 231-3473.

If you have questions about the Continuing Education program, please contact the Education Department.